AI app aims to boost nutrition and survival in pancreatic cancer patients
NCT ID NCT07167264
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study is testing whether an AI-powered mobile app can help assess and improve nutrition in 200 patients who have had surgery for pancreatic cancer. The app collects data on symptoms like pain, appetite, and weight, and uses artificial intelligence to guide follow-up care. The goal is to see if this approach can improve patients' recovery and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AI-powered mobile app for nutritional assessment and follow-up
What this could lead to
If successful, this could provide a simple, AI-driven tool to better manage nutrition and follow-up care for pancreatic cancer survivors, potentially improving their quality of life and survival.
What could go wrong
This is an early feasibility study with no control group, so results may not prove the app directly improves outcomes. The AI model may not work well for all patients, and the study is small.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai General Hospital
RECRUITINGShanghai, Shanghai Municipality, 200080, China
Contact Phone: •••-•••-•••• Email: •••••@•••••